Page last updated: 2024-10-24

buspirone and Depressive Disorder, Treatment-Resistant

buspirone has been researched along with Depressive Disorder, Treatment-Resistant in 3 studies

Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.

Depressive Disorder, Treatment-Resistant: Failure to respond to two or more trials of antidepressant monotherapy or failure to respond to four or more trials of different antidepressant therapies. (Campbell's Psychiatric Dictionary, 9th ed.)

Research Excerpts

ExcerptRelevanceReference
" Data were derived from an earlier study, designed to compare efficacy and tolerability of fixed dosage of extended-release venlafaxine, mitazapine, paroxetine, and risperidone, sodium valproate, buspirone, trazodone or thyroid hormone augmenting to paroxetine in those patients."2.78Difference in remission in a Chinese population with anxious versus nonanxious treatment-resistant depression: a report of OPERATION study. ( Cao, L; Chen, J; Fang, Y; Hong, W; Peng, D; Wu, Z; Yuan, C; Zhang, C, 2013)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Caldiroli, A1
Capuzzi, E1
Tagliabue, I1
Capellazzi, M1
Marcatili, M1
Mucci, F1
Colmegna, F1
Clerici, M1
Buoli, M1
Dakanalis, A1
Wu, Z1
Chen, J1
Yuan, C1
Hong, W1
Peng, D1
Zhang, C1
Cao, L1
Fang, Y1
Gaynes, BN1
Dusetzina, SB1
Ellis, AR1
Hansen, RA1
Farley, JF1
Miller, WC1
Stürmer, T1

Reviews

1 review available for buspirone and Depressive Disorder, Treatment-Resistant

ArticleYear
Augmentative Pharmacological Strategies in Treatment-Resistant Major Depression: A Comprehensive Review.
    International journal of molecular sciences, 2021, Dec-02, Volume: 22, Issue:23

    Topics: Anticonvulsants; Antidepressive Agents; Antidepressive Agents, Second-Generation; Buspirone; Central

2021

Trials

2 trials available for buspirone and Depressive Disorder, Treatment-Resistant

ArticleYear
Difference in remission in a Chinese population with anxious versus nonanxious treatment-resistant depression: a report of OPERATION study.
    Journal of affective disorders, 2013, Sep-25, Volume: 150, Issue:3

    Topics: Adolescent; Adult; Aged; Antidepressive Agents; Anxiety Disorders; Buspirone; China; Comorbidity; Cy

2013
Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STAR*D.
    Journal of clinical psychopharmacology, 2012, Volume: 32, Issue:1

    Topics: Adolescent; Adult; Aged; Antidepressive Agents, Second-Generation; Bupropion; Buspirone; Citalopram;

2012